A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases

Mickael Arnaud (), Francesco Salvo, Ismaïl Ahmed, Philip Robinson, Nicholas Moore, Bernard Bégaud, Pascale Tubert-Bitter and Antoine Pariente
Additional contact information
Mickael Arnaud: Université de Bordeaux
Francesco Salvo: Université de Bordeaux
Ismaïl Ahmed: Université de Versailles St Quentin
Philip Robinson: Université de Bordeaux
Nicholas Moore: Université de Bordeaux
Bernard Bégaud: Université de Bordeaux
Pascale Tubert-Bitter: Université de Versailles St Quentin
Antoine Pariente: Université de Bordeaux

Drug Safety, 2016, vol. 39, issue 3, No 7, 260 pages

Abstract: Abstract Introduction The two methods for minimizing competition bias in signal of disproportionate reporting (SDR) detection—masking factor (MF) and masking ratio (MR)—have focused on the strength of disproportionality for identifying competitors and have been tested using competitors at the drug level. Objectives The aim of this study was to develop a method that relies on identifying competitors by considering the proportion of reports of adverse events (AEs) that mention the drug class at an adequate level of drug grouping to increase sensitivity (Se) for SDR unmasking, and its comparison with MF and MR. Methods Reports in the French spontaneous reporting database between 2000 and 2005 were selected. Five AEs were considered: myocardial infarction, pancreatitis, aplastic anemia, convulsions, and gastrointestinal bleeding; related reports were retrieved using standardized Medical Dictionary for Regulatory Activities (MedDRA®) queries. Potential competitors of AEs were identified using the developed method, i.e. Competition Index (ComIn), as well as MF and MR. All three methods were tested according to Anatomical Therapeutic Chemical (ATC) classification levels 2–5. For each AE, SDR detection was performed, first in the complete database, and second after removing reports mentioning competitors; SDRs only detected after the removal were unmasked. All unmasked SDRs were validated using the Summary of Product Characteristics, and constituted the reference dataset used for computing the performance for SDR unmasking (area under the curve [AUC], Se). Results Performance of the ComIn was highest when considering competitors at ATC level 3 (AUC: 62 %; Se: 52 %); similar results were obtained with MF and MR. Conclusion The ComIn could greatly minimize the competition bias in SDR detection. Further study using a larger dataset is needed.

Date: 2016
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s40264-015-0375-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0375-8

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-015-0375-8

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().